Stake Announced
Incyte stake in Genesis Molecular AI
US$40m consideration
Announced 3 Jun 2026
Advisers
Genesis Molecular AI
Target
Not disclosed
- Target
- Genesis Molecular AI
- Acquirer
- Incyte
- Target based in
- United States (unverified)
- Buyer based in
- United States
- Structure
- Minority stake
- Sector
- AI
- Tags
- AI, Drug Development, Biotech
In the league tables
Similar deals
- Eli Lilly acquisition of Engage Bio May 2026 · US$202m · Biotech
- BioMarin Pharmaceutical acquisition of Alesta Therapeutics Aug 2026 · US$275m · Biotech
- Bayer acquisition of Perfuse Therapeutics May 2026 · US$300m · Biotech
- Gyre Therapeutics acquisition of Cullgen Mar 2026 · US$300m · Biotech
- Dimerix acquisition of MTX652 Jul 2026 · US$292m · Biotech
